<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="11" ids="22586">Antioxidants</z:chebi> effectively reduce <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion (IR) injury </plain></SENT>
<SENT sid="1" pm="."><plain>The cardioprotective effects of <z:chebi fb="0" ids="15864">luteolin</z:chebi>, a <z:chebi fb="5" ids="47916">flavonoid</z:chebi> that exhibits <z:chebi fb="11" ids="22586">antioxidant</z:chebi> properties and is widely available in many fruits and vegetables, were examined in rats subjected to myocardial IR injury </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: Rats were subjected to <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">myocardial ischemia</z:e> or reperfusion injury to evaluate the antiarrhythmic effects of <z:chebi fb="0" ids="15864">luteolin</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Myocardial <z:mpath ids='MPATH_124'>infarct</z:mpath> size was determined histochemically with triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining of the left ventricle </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="15864">Luteolin</z:chebi> was administered intravenously 15min before occlusion of the coronary artery </plain></SENT>
<SENT sid="5" pm="."><plain>The incidence and duration of <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> and <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> and mortality during <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">myocardial ischemia</z:e> were significantly reduced by <z:chebi fb="0" ids="15864">luteolin</z:chebi> (10µg/kg) </plain></SENT>
<SENT sid="6" pm="."><plain>Similarly, <z:chebi fb="0" ids="15864">luteolin</z:chebi> (1µg/kg) reduced <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> and mortality during the reperfusion phase </plain></SENT>
<SENT sid="7" pm="."><plain>Pretreatment with <z:chebi fb="0" ids="15864">luteolin</z:chebi> decreased plasma <z:chebi fb="4" ids="24996">lactate</z:chebi> dehydrogenase and nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) levels </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="15864">Luteolin</z:chebi> (10µg/kg) significantly reduced the myocardial <z:mpath ids='MPATH_124'>infarct</z:mpath> size, as well as malondialdehyde production in tissue samples of myocardial IR injury </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="15864">Luteolin</z:chebi> also downregulated inducible NO synthase protein and <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression, but did not significantly alter neuronal NO synthase or endothelial NO synthase expression </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: <z:chebi fb="0" ids="15864">Luteolin</z:chebi> is capable of protecting the myocardium against IR injury </plain></SENT>
<SENT sid="11" pm="."><plain>The actions of <z:chebi fb="0" ids="15864">luteolin</z:chebi> are at least partly mediated through downregulation of NO production and its own <z:chebi fb="11" ids="22586">antioxidant</z:chebi> properties </plain></SENT>
</text></document>